nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—TYR—hair follicle—head and neck cancer	0.079	0.15	CbGeAlD
Mimosine—CCL2—exocrine gland—head and neck cancer	0.0476	0.0907	CbGeAlD
Mimosine—SHMT1—Vincristine—Vinblastine—head and neck cancer	0.0426	1	CbGdCrCtD
Mimosine—CCL2—mouth—head and neck cancer	0.0356	0.0678	CbGeAlD
Mimosine—CCL2—neck—head and neck cancer	0.0304	0.058	CbGeAlD
Mimosine—TYR—lymphoid tissue—head and neck cancer	0.0278	0.0529	CbGeAlD
Mimosine—SHMT1—parotid gland—head and neck cancer	0.0268	0.051	CbGeAlD
Mimosine—SHMT1—saliva-secreting gland—head and neck cancer	0.0256	0.0488	CbGeAlD
Mimosine—CCL2—parotid gland—head and neck cancer	0.0248	0.0472	CbGeAlD
Mimosine—SHMT1—One Carbon Metabolism—TYMS—head and neck cancer	0.0248	0.0573	CbGpPWpGaD
Mimosine—TYR—head—head and neck cancer	0.0224	0.0426	CbGeAlD
Mimosine—SHMT1—Trans-sulfuration and one carbon metabolism—TYMS—head and neck cancer	0.0222	0.0515	CbGpPWpGaD
Mimosine—CCL2—connective tissue—head and neck cancer	0.0218	0.0416	CbGeAlD
Mimosine—CCL2—epithelium—head and neck cancer	0.0207	0.0395	CbGeAlD
Mimosine—SHMT1—trachea—head and neck cancer	0.0198	0.0376	CbGeAlD
Mimosine—CCL2—trachea—head and neck cancer	0.0183	0.0349	CbGeAlD
Mimosine—SHMT1—lymphoid tissue—head and neck cancer	0.0172	0.0328	CbGeAlD
Mimosine—CCL2—lymphoid tissue—head and neck cancer	0.016	0.0304	CbGeAlD
Mimosine—TYR—lymph node—head and neck cancer	0.0157	0.0299	CbGeAlD
Mimosine—SHMT1—thyroid gland—head and neck cancer	0.0156	0.0298	CbGeAlD
Mimosine—CCL2—thyroid gland—head and neck cancer	0.0145	0.0276	CbGeAlD
Mimosine—SHMT1—head—head and neck cancer	0.0139	0.0264	CbGeAlD
Mimosine—CCL2—head—head and neck cancer	0.0129	0.0245	CbGeAlD
Mimosine—CCL2—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.0126	0.0291	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—SOD2—head and neck cancer	0.0124	0.0286	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—GPX1—head and neck cancer	0.0118	0.0273	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.0104	0.0241	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SOD2—head and neck cancer	0.0102	0.0237	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—CASP8—head and neck cancer	0.0101	0.0234	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—GPX1—head and neck cancer	0.00978	0.0226	CbGpPWpGaD
Mimosine—SHMT1—lymph node—head and neck cancer	0.00971	0.0185	CbGeAlD
Mimosine—CCL2—lymph node—head and neck cancer	0.009	0.0171	CbGeAlD
Mimosine—CCL2—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00859	0.0199	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL2—head and neck cancer	0.00848	0.0196	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—head and neck cancer	0.00826	0.0191	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00814	0.0188	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—PIK3CA—head and neck cancer	0.00796	0.0184	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00777	0.018	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—STAT3—head and neck cancer	0.00713	0.0165	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—STAT3—head and neck cancer	0.00713	0.0165	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.007	0.0162	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—MAPK3—head and neck cancer	0.00681	0.0158	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—BCL2L1—head and neck cancer	0.00662	0.0153	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—MAPK1—head and neck cancer	0.00648	0.015	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL2—head and neck cancer	0.00644	0.0149	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MAPK3—head and neck cancer	0.00616	0.0142	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MAPK1—head and neck cancer	0.00586	0.0136	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00576	0.0133	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00563	0.013	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—PIK3CA—head and neck cancer	0.00563	0.013	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	0.00557	0.0129	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—CASP8—head and neck cancer	0.00541	0.0125	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL2—head and neck cancer	0.00534	0.0123	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—KISS1—head and neck cancer	0.00533	0.0123	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—HRAS—head and neck cancer	0.00521	0.012	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL2—head and neck cancer	0.00509	0.0118	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK3—head and neck cancer	0.00496	0.0115	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CCND1—head and neck cancer	0.00496	0.0115	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—PTEN—head and neck cancer	0.00479	0.0111	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—UROD—head and neck cancer	0.00478	0.011	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK1—head and neck cancer	0.00472	0.0109	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—VEGFA—head and neck cancer	0.00459	0.0106	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00457	0.0106	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—STAT3—head and neck cancer	0.00454	0.0105	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GRP—head and neck cancer	0.00439	0.0102	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK3—head and neck cancer	0.00434	0.01	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—head and neck cancer	0.00415	0.00961	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—head and neck cancer	0.00413	0.00956	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK1—head and neck cancer	0.00413	0.00956	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—PTGS2—head and neck cancer	0.00362	0.00836	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.00358	0.00828	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—head and neck cancer	0.00347	0.00802	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—head and neck cancer	0.00343	0.00792	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL2—head and neck cancer	0.00335	0.00775	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—head and neck cancer	0.00335	0.00774	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HRAS—head and neck cancer	0.00332	0.00767	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK3—head and neck cancer	0.00329	0.00761	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—head and neck cancer	0.00327	0.00756	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCND1—head and neck cancer	0.00327	0.00756	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK1—head and neck cancer	0.00313	0.00724	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—GRP—head and neck cancer	0.00309	0.00714	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—head and neck cancer	0.00293	0.00677	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KISS1—head and neck cancer	0.00274	0.00633	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK3—head and neck cancer	0.00269	0.00623	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK1—head and neck cancer	0.00256	0.00593	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—EGFR—head and neck cancer	0.00256	0.00593	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.00251	0.00581	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRP—head and neck cancer	0.00225	0.00521	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.00222	0.00513	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—head and neck cancer	0.00215	0.00498	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NAT2—head and neck cancer	0.00198	0.00459	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—DPYD—head and neck cancer	0.00174	0.00402	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—YAP1—head and neck cancer	0.00165	0.00382	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KISS1—head and neck cancer	0.00162	0.00374	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRP—head and neck cancer	0.00133	0.00308	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT6—head and neck cancer	0.00129	0.00299	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YAP1—head and neck cancer	0.00114	0.00264	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TYMS—head and neck cancer	0.000991	0.00229	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTM1—head and neck cancer	0.000979	0.00227	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPX1—head and neck cancer	0.000938	0.00217	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1A1—head and neck cancer	0.000928	0.00215	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOTCH1—head and neck cancer	0.000888	0.00205	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—head and neck cancer	0.000659	0.00152	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—head and neck cancer	0.0006	0.00139	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—head and neck cancer	0.000575	0.00133	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—head and neck cancer	0.000552	0.00128	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH1—head and neck cancer	0.000515	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—head and neck cancer	0.000514	0.00119	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK3—head and neck cancer	0.000491	0.00114	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK3—head and neck cancer	0.000483	0.00112	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—head and neck cancer	0.000482	0.00111	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK1—head and neck cancer	0.000467	0.00108	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGFR—head and neck cancer	0.000467	0.00108	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK1—head and neck cancer	0.000459	0.00106	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EGFR—head and neck cancer	0.000459	0.00106	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—head and neck cancer	0.000406	0.000938	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—head and neck cancer	0.000398	0.000921	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—head and neck cancer	0.000375	0.000868	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—head and neck cancer	0.000369	0.000853	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—head and neck cancer	0.000355	0.00082	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—head and neck cancer	0.000346	0.000799	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—head and neck cancer	0.00034	0.000786	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—head and neck cancer	0.000334	0.000772	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—head and neck cancer	0.000331	0.000766	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—head and neck cancer	0.000325	0.000753	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—head and neck cancer	0.000301	0.000697	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—head and neck cancer	0.000298	0.00069	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK3—head and neck cancer	0.000285	0.000659	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—head and neck cancer	0.000277	0.000642	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK1—head and neck cancer	0.000271	0.000627	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGFR—head and neck cancer	0.000271	0.000627	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—head and neck cancer	0.000235	0.000544	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—head and neck cancer	0.000228	0.000527	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—head and neck cancer	0.000218	0.000504	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—head and neck cancer	0.000192	0.000445	CbGpPWpGaD
